PEGylated PLGA nanospheres optimized by design of experiments for ocular administration of dexibuprofen—in vitro, ex vivo and in vivo characterization
Elena Sánchez‐López(Instituto de Salud Carlos III), María L. García(Institut de Nanociència i Nanotecnologia de la Universitat de Barcelona), Amanda Cano(Biomedical Research Networking Center on Neurodegenerative Diseases), Marta Espina(Institut de Nanociència i Nanotecnologia de la Universitat de Barcelona), Miren Ettcheto(Instituto de Salud Carlos III), Ana Cristina Calpena(Institut de Nanociència i Nanotecnologia de la Universitat de Barcelona), Eliana B. Souto(Universidade do Porto), Antoni Camins(Biomedical Research Networking Center on Neurodegenerative Diseases), M.A. Egea(Universitat de Barcelona), Amélia M. Silva(University of Trás-os-Montes and Alto Douro)
Cited by 147
Related Papers
Metal-Based Nanoparticles as Antimicrobial Agents: An Overview
|Nanomaterials|2020|1.4k
Therapeutic potential of venom peptides
|Nature Reviews Drug Discovery|2003|786
Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery
|International Journal of Pharmaceutics|2004|664
Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model
|Journal of Controlled Release|2019|330
Microemulsions and Nanoemulsions in Skin Drug Delivery
|Bioengineering|2022|291